This free script provided by
JavaScript Kit


Catalog #:

IN0095-0.1mg USD138.0
IN0095-1mg USD990.0

References for KT5823 :

1. Beyer, S., Lakshmanan, A., Liu, Y. Y., Zhang, X., Wapnir, I., Smolenski, A., and Jhiang, S. KT5823 differentially modulates sodium iodide symporter expression, activity, and glycosylation between thyroid and breast cancer cells. Endocrinology, 152: 782-792.

2. Chan, S. L. and Fiscus, R. R. Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG. Mol Hum Reprod, 9: 775-783, 2003.

3. Miyoshi, K., Kawakami, N., Horio, S., and Fukui, H. Inhibition of histamine H1 receptor downregulation by KT5823, a protein kinase G inhibitor. Methods Find Exp Clin Pharmacol, 25: 343-347, 2003.

4. Burkhardt, M., Glazova, M., Gambaryan, S., Vollkommer, T., Butt, E., Bader, B., Heermeier, K., Lincoln, T. M., Walter, U., and Palmetshofer, A. KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J Biol Chem, 275: 33536-33541, 2000.

5. Wyatt, T. A., Pryzwansky, K. B., and Lincoln, T. M. KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. Res Commun Chem Pathol Pharmacol, 74: 3-14, 1991.

Certificate of Analysis/MSDS is available upon request with lot number

Home | Contact | Support | Privacy Policy, Terms Warranty | Apycom jQuery Menus